Comments
Bayer's Nexavar meets goal in thyroid cancer trial
04.01.2013. | FRANKFURT (Reuters) - German drugmaker Bayer said its cancer treatment Nexavar reached a goal of improving the survival of patients with a certain type of thyroid cancer in a late-stage clinical trial....
